ArticleBlood advances2024

Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.

Andrew A Lane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.